ACACIA RESEARCH CORP (ACTG)
ACACIA RESEARCH CORP (ACTG)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) income including noncontrolling interests in subsidiaries | -17,601 | 4,773 | -2,394 | 22,091 |
| Depreciation, depletion and amortization | 8,487 | 10,457 | 10,836 | 22,055 |
| Accretion of asset retirement obligation | -455 | -435 | -432 | -867 |
| Gain on disposal of assets | 487 | -169 | NaN | NaN |
| Compensation expense for share-based awards | 1,000 | 1,987 | 1,875 | 1,876 |
| Loss (gain) on foreign currency exchange | -59 | 9 | -30 | 435 |
| Change in fair value of equity securities | -1,559 | 2,750 | 900 | -2,558 |
| Loss (gain) on sale of equity securities | -605 | -3,537 | 0 | 3,512 |
| Unrealized loss on derivatives | -9,726 | 2,223 | 706 | 789 |
| Deferred income taxes | -3,424 | 1,230 | -37 | 3,646 |
| Accounts receivable | 2,537 | -948 | 3,785 | -3,501 |
| Inventories | -3,143 | 783 | 765 | -1,760 |
| Prepaid expenses and other assets | -8,620 | 2,002 | -830 | 4,114 |
| Amortization of debt discount and issuance costs | NaN | NaN | NaN | 95 |
| Accounts payable and accrued expenses | -6,211 | -2,312 | 2,904 | 2,551 |
| Royalties and contingent legal fees payable | -131 | -217 | 1,298 | 231 |
| Deferred revenue | 140 | -90 | 24 | 164 |
| Net cash provided by operating activities | 3,403 | 13,150 | 9,547 | 52,545 |
| Acquisition, net of cash acquired and working capital adjustments | 0 | 0 | 0 | -1,230 |
| Patent acquisition | 1,750 | 0 | 0 | 0 |
| Proceeds from sale of floor mat assets | NaN | 2,988 | NaN | NaN |
| Purchases of equity securities | 0 | 7,337 | 4,825 | 12,543 |
| Sales of equity securities | 1,181 | 16,192 | 0 | 15,165 |
| Purchases of loans receivable | NaN | 11,819 | 3,364 | NaN |
| Proceeds from loans receivable | -7,200 | NaN | NaN | NaN |
| Purchases of property and equipment | 740 | 1,119 | 461 | 940 |
| Net additions to oil and gas properties | 8,454 | 5,213 | 5,598 | 3,363 |
| Proceeds from disposition of property and equipment | 1,581 | NaN | NaN | NaN |
| Net cash (used in) provided by investing activities | -982 | -6,308 | -14,248 | -451 |
| Proceeds from exercise of stock options | NaN | 0 | 0 | 30 |
| Repurchase of common stock | NaN | 0 | 0 | NaN |
| Contributions from noncontrolling interest | NaN | 0 | 0 | 0 |
| Borrowings on the benchmark revolving credit facility | NaN | 1,000 | 4,000 | 0 |
| Paydown of benchmark revolving credit facility | 0 | 0 | 3,500 | 8,500 |
| Borrowings on the deflecto facility | NaN | 0 | NaN | NaN |
| Paydown of deflecto facility | 1,581 | 2,988 | 10,900 | 1,200 |
| Taxes paid related to net share settlement of share-based awards | 320 | 5 | 0 | 670 |
| Net cash used in financing activities | -1,901 | -1,993 | -10,400 | -10,340 |
| Effect of exchange rates on cash and cash equivalents | 268 | 90 | 160 | 1,087 |
| Increase (decrease) in cash and cash equivalents | 788 | 4,939 | -14,941 | 42,841 |
| Cash and cash equivalents, beginning of period | 306,719 | 301,780 | 273,880 | NaN |
| Cash and cash equivalents, end of period | 307,507 | 306,719 | 301,780 | NaN |